Search Results - "Hussian, D."

Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience by Steger, G.G., Bartsch, R., Wenzel, C., Pluschnig, U., Hussian, D., Sevelda, U., Locker, G.J., Gnant, M.F., Jakesz, R., Zielinski, C.C.

“…Fulvestrant (‘Faslodex’) is a new oestrogen receptor (ER) antagonist with no agonist effects. This report describes the experience of a single centre including…”
Get full text

Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study by Bartsch, Rupert, Wenzel, Catharina, Hussian, Dagmar, Pluschnig, Ursula, Sevelda, Ursula, Koestler, Wolfgang, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G

“…Combining trastuzumab and chemotherapy is standard in her2/neu overexpressing advanced breast cancer. It is not established however, whether trastuzumab…”
Get full text

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study by WENZEL, Catharina, HUSSIAN, Dagmar, BARTSCH, Rupert, PLUSCHNIG, Ursula, LOCKER, Gottfried J, RUDAS, Margarethe, GNANT, Michael F, JAKESZ, Raimund, ZIELINSKI, Christoph C, STEGER, Guenther G

“…Combining anthracyclines and taxanes are to date the most active cytotoxic treatment option in the neoadjuvant and palliative therapy of breast cancer…”
Get full text

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment by Bartsch, Rupert, Wenzel, Catharina, Pluschnig, Ursula, Hussian, Dagmar, Sevelda, Ursula, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G

“…At many centres tumour markers are used to detect disease recurrence and to monitor response to therapy in patients with advanced disease, although the real…”
Get full text

Prognostic value of tumor markers CA 15–3 and CEA during fulvestrant treatment by Bartsch, R., Steger, G., Wenzel, C., Pluschnig, U., Hussian, D., Sevelda, U., Mader, R., Zielinski, C. C.

“…Abstract only…”
Get full text

Fulvestrant (FUL) and goserelin (GOS) in premenopausal women with advanced, hormone-sensitive breast cancer: A pilot study by Steger, G., Bartsch, R., Wenzel, C., Hussian, D., Sevelda, U., Pluschnig, U., Mader, R., Zielinski, C. C.

“…Abstract only…”
Get full text

Single administration of pegylated filgrastim once per cycle compared to daily filgrastim in patients with primary breast cancer receiving neoadjuvant chemotherapy by Wenzel, C., Bartsch, R., Hussian, D., Pluschnig, U., Locker, G. J., Sevelda, U., Zielinski, C. C., Steger, G. G.

“…Abstract only…”
Get full text

Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer : results from a pilot trial by BARTSCH, Rupert, WENZEL, Catharina, PLUSCHNIG, Ursula, HUSSIAN, Dagmar, SEVELDA, Ursula, LOCKER, Gottfried J, MADER, Robert, ZIELINSKI, Christoph C, STEGER, Guenther G

“…We evaluated the efficacy of oral vinorelbine (OV) (Navelbine oral Boeringer-Ingelheim Austria) in patients with advanced breast cancer as first-line therapy…”
Get full text

Oral vinorelbine in the treatment of advanced breast cancer by Bartsch, R., Pluschnig, U., Wenzel, C., Hussian, D., Locker, G. J., Mader, R., Zielinski, C. C., Steger, G. G.

“…Abstract only…”
Get full text

Oral vinorelbine in the treatment of advanced breast cancer by Bartsch, R., Pluschnig, U., Wenzel, C., Hussian, D., Locker, G. J., Mader, R., Zielinski, C. C., Steger, G. G.

“…Abstract only…”
Get full text

Feasibility of docetaxel, epirubicin, and capecitabine (TEX) plus pegfilgrastim as neoadjuvant treatment for primary breast cancer: A pilot stud by Wenzel, C., Hussian, D., Bartsch, R., Pluschnig, U., Locker, G. J., Gnant, M., Jakesz, R., Zielinski, C. C., Steger, G. G.

“…Abstract only…”
Get full text

Feasibility of docetaxel, epirubicin, and capecitabine (TEX) plus pegfilgrastim as neoadjuvant treatment for primary breast cancer: A pilot stud by Wenzel, C., Hussian, D., Bartsch, R., Pluschnig, U., Locker, G. J., Gnant, M., Jakesz, R., Zielinski, C. C., Steger, G. G.

“…Abstract only…”
Get full text

Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer by Wenzel, Catharina, Bartsch, Rupert, Locker, Gottfried J, Hussian, Dagmar, Pluschnig, Ursula, Sevelda, Ursula, Gnant, Michael F, Jakesz, Raimund, Zielinski, Christoph C, Steger, Guenther G

“…The objective of this pilot trial was to evaluate the safety and activity profile of epidoxorubicin, docetaxel and oral capecitabine plus pegfilgrastim (TEX+P)…”
Get full text

Darbepoetin ?? as treatment for anemia in patients receiving chemotherapy: a single-center experience by Bartsch, Rupert, Wenzel, Catharina, Sevelda, Ursula, Hussian, Dagmar, Pluschnig, Ursula, Locker, Gottfried J., Mader, Robert, Zielinski, Christoph C., Steger, Guenther G.

Get full text

Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome by Wenzel, Catharina, Bartsch, Rupert, Hussian, Dagmar, Pluschnig, Ursula, Locker, Gottfried J, Sevelda, Ursula, Zielinski, Christoph C, Steger, Guenther G

“…Hypercalcemia of malignancy remains a common metabolic complication of advanced cancer often resulting in considerable morbidity and diminishing life quality…”
Get full text

903 Capecitabine-monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinoma by Wenzel, C., Bartsch, R., Pluschinig, U., Hussian, D., Zielinski, C.C., Steger, G.G.

Get full text

442 Fulvestrant (‘Faslodex’) demonstrates clinical benefit in heavily pre-treated patients with metastatic breast cancer by Steger, G.G., Barisch, R., Wenzel, C., Hussian, D., Plusching, U., Mader, R.M., Zielinski, C.C.

Get full text

Preoperative second-line chemotherapy induces objective responses in primary breast cancer by Wenzel, Catharina, Locker, Gottfried J, Bartsch, Rupert, Pluschnig, Ursula, Hussian, Dagmar, Zielinski, Christoph C, Rudas, Margarethe, Gnant, Michael F, Jakesz, Raimund, Steger, Guenther G

“…Preoperative chemotherapy in patients with primary breast cancer results in high response rates, allowing breast-conserving surgery in patients primarily not…”
Get full text

Outpatient balloon vaginoplasty for treatment of vaginal aplasia by El Saman, Ali M., MD, Tawfik, Reda M., MD, Hussian, Mostafa, MD, Abdella, Mohamed S., MD

“…We evaluated the feasibility and operative and postoperative outcomes of office balloon vaginoplasty. Office balloon vaginoplasty was performed successfully…”
Get full text